Impact BioMedical (IBO) Registration Filing summary

Management team and governance

• CEO and President is Frank D. Heuszel, who also serves as Chairman of the Board.

• Jason Grady, Todd D. Macko, Mark Suseck, Dr. Elise Brownell, Melissa Sims, Castel Hibbert, Christian Zimmerman, and David Keene serve as directors or executive officers.

• The company has established Compensation, Audit, and Nominating and Corporate Governance Committees.

Offering details and pricing

• Registration statement filed for a firm commitment initial public offering of common stock and representative's warrants.

• Shares and warrants to be issued and sold as described in the registration statement.

• The offering will commence as soon as practicable after the effective date.

Underwriters and syndicate

• Revere Securities, LLC is named as the underwriter in the form of the underwriting agreement.